Wikidata

(Q61902326)

English

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

clinical trial

In more languages

Statements

short name
MER3101 (English)
0 references
title
MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes (English)
0 references
start time
January 2019
0 references
end time
4 April 2022
0 references
number of participants
28
0 references
minimum age
18 year
0 references
maximum age
45 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61902326&oldid=2108865901"